BoxOne Ventures

BoxOne Ventures Research Company Overview BoxOne Ventures is a Montreal-based investment firm founded in 2010 by Josh Felker and Arvind Ramanathan. The firm operates on an evergreen capital model, investing its own capital rather than managing third-party limited partner (LP) money. This distinctive approach gives BoxOne unusual patience and flexibility in supporting entrepreneurs from napkin-stage through IPO. Investment Philosophy & Thesis BoxOne Ventures focuses on early-stage companies developing transformative technologies across the most impactful and fast-changing sectors. The firm believes in backing passionate, emerging talent and exceptional founders with strong underlying technologies. They emphasize: Sector Diversity : Biotechnology, deep tech, frontier software/crypto, food innovation, longevity science, AI/data analytics, and clean energy Technical Excellence : Companies with strong underlying technologies and scientific rigor Founder Quality : Exceptional founders building products that tackle fundamental problems Global Perspective : Portfolio spans worldwide, not limited to specific geographies The firm's description emphasizes enabling "passionate, emerging talent and supercharges them early to maximize their impact and potential." Stage & Check Size Stage Focus : Pre-seed through Series A and beyond, with flexibility to follow through IPO Early-stage primary focus (napkin-stage through seed) 180+ companies invested across spectrum Check Size Range : $100K - $5M Sweet spot: $1.5M Flexible sizing based on opportunity Portfolio Characteristics As of September 2025, BoxOne Ventures has invested in 87 companies with 4 new investments in the last 12 months , indicating active but selective deployment. The portfolio is highly diverse: Sector Distribution Biotechnology & Life Sciences (40%+) Antibody engineering and directed evolution platforms Gene therapy and protein engineering Cell therapy and cellular bioengineering Computational biology and drug discovery Precision medicine and digital health Notable companies: Juvena Therapeutics ($41M raised), protein engineering startups, rare disease therapeutics Food & Agtech (15%+) Cellular agriculture (real milk without cows, protein production) Sustainable ingredient production Crop intelligence and ag-tech automation Food waste transformation Plant-based nutrition and functional foods AI, Data & Analytics (15%+) LLM-powered platforms and AI agents Computational biology platforms Data analytics and business intelligence Market prediction and intelligence tools Observability and monitoring Fintech & Markets (10%) Prediction markets and social trading platforms Investor platforms and market data tools Crypto/blockchain projects (early involvement) Real estate and rental marketplaces Climate & Energy (10%) Iron fuel clean energy storage Engineered algae for fuel production Sustainable materials and biosurfactants Environmental impact technologies Other Deep Tech (10%) Hardware and semiconductors Robotics and automation AR/VR and spatial computing Hardware innovation platforms Team & Organization Founders: Josh Felker (Co-founder, Managing Partner): Previously co-founded Vigilant Global, a Montreal-based proprietary trading firm that pioneered low-latency news-driven trading and FPGA technology. Brings systematic, quantitative approach to investment. Also co-founder of Nascent (crypto/open finance). Investment focus: $100K-$5M range. Arvind Ramanathan (Co-founder, Partner): Co-founder of Vigilant Global with Josh. Deep expertise in systematic investing and technology infrastructure. Investment Team: Eric Bellerive (Venture Partner) Felicity (Investment Manager) - Specializes in cleantech, foodtech, and agtech Rebecca (Investment Manager) Mike (AI & Engineering Lead) - Technical guidance for portfolio companies Operations: Nathaniel (Head of Finance) Tamara (Workspace Coordinator) BoxOne operates from a collaborative workspace at the historic RCA Building in Montreal (1001 Lenoir St., Suite B532), hosting investors, entrepreneurs, and ecosystem builders. Investment Activity & Lead Tendency Recent Activity (2025): September 2025: Investment in Nutrumami (food products) August-September 2025: Multiple investments across biotech, foodtech, and AI sectors Consistent monthly investment activity through 2025 Lead Tendency : Mixed - BoxOne participates as both lead and follow investor. Appears to be comfortable taking board seats and leading rounds for chosen investments, but also follows strong syndicates. Fund Status : Actively deploying capital (as of Q4 2025) Geographic Focus Primarily North America and Europe, with global portfolio: Montreal headquarters and operational hub Active in US, Canada, Europe Selective investments in global biotech hubs Notable Exits & Achievements Multiple exits across portfolio (exact numbers proprietary, but publicly available trades include early crypto positions) Portfolio includes companies that achieved significant funding rounds ($40M+) Investments across diverse exit scenarios (acquisitions, IPOs, ongoing scaling) Decision Process & Involvement Partnership approach to investment decisions Technical due diligence emphasis (AI & Engineering Lead on team) Board involvement typical for invested companies Founder-friendly thesis (support through multiple stages) Founder Preferences BoxOne seeks: Passionate founders with clear technical vision Exceptional scientific and technical talent Teams solving fundamental problems Global perspective and ambition Founders willing to accept long-term patient capital Competitive Advantages Evergreen Capital Model : No LP constraints, can hold companies longer Technical Expertise : AI/Engineering lead provides operational guidance Founder Flexibility : Can deploy across all stages, not constrained by fund life Deep Sector Expertise : Particular strength in biotech and deep tech Montreal Ecosystem : Part of strong Canadian tech/biotech ecosystem Systematic Approach : Quantitative background from trading firm roots Investment Approach BoxOne combines: Systematic Analysis : Founded by proprietary traders with quantitative methods Hands-on Support : AI/Engineering and specialized investment managers Founder-First Philosophy : Long-term patient capital supporting vision Sector Specialization : Deep expertise in biotech, AI, food, energy Global Sourcing : Network across North America and Europe Notable Portfolio Segments Bioengineering & Synthetic Biology : Large concentration of protein engineering, cell therapy, and directed evolution companies - aligned with long-term theses in precision medicine and biomanufacturing. AI Applications : Focus on computational biology and data-driven discovery - enabling next wave of biotech innovation. Sustainable Food : Investments in cellular agriculture, precision fermentation, and alt-protein - addressing fundamental food system challenges. Summary BoxOne Ventures is a patient, technically-driven capital partner for founders solving deep technology challenges. The evergreen fund model, founder-friendly approach, and technical expertise make them particularly valuable for long-development-cycle companies in biotech and deep tech. Their systematic investing background combined with sector specialization creates a unique approach to early-stage venture investing.